The absence of associations in our sample, which included a range of AD stages, could also suggest that any influence of sαKl on non-specific markers like NfL, GFAP, and Ng is more detectable in preclinical or earlier stages of AD pathology, aligning with Driscoll et al.'s findings in cognitively unimpaired adults. Here, GFAP is linked to Alzheimer disease.